期刊文献+

结核分枝杆菌与树突状细胞相互作用的研究进展 被引量:2

Progress on interaction between Mycobacterium tuberculosis and dendritic cell
原文传递
导出
摘要 结核分枝杆菌(Mycobacterium tuberculosis, MTB)感染引起的结核病是严重威胁人类健康的慢性传染病。树突状细胞(dendritic cell, DC)是重要的抗原提呈细胞及连接机体固有免疫和适应性免疫应答的桥梁细胞。DC通过表面表达受体识别并吞噬病原体,参与抗原提呈,并发育成熟,同时分泌不同类型的细胞因子,决定T细胞分化方向,最终影响细胞免疫应答效应。在MTB感染过程中各成分与DC相互作用的特性研究,是分析MTB毒力基因及致病机理的基础,并可为结核疫苗研究提供候选优势抗原。现对目前MTB与DC的相互作用机制的研究进展作一概述。 Tuberculosis caused by Mycobacterium tuberculosis(MTB) is a serious chronic infectious disease. Dendritic cell(DC) is major antigen-presenting cell(APC) and bridges both innate with adaptive immune system function in human body. Recognizing and phagocytizing pathogens by the cell surface receptors, DC participates in the progress of antigen presentation. Simultaneously, with DC developing constantly, it secretes different types of cytokines and mediates the direction of T cell differentiation, and finally affects the anti-MTB immune effects of cellular immune response. Investigating the characteristics of the interaction between the components in MTB infection and DC can help to analyze the function of MTB virulence genes and pathogenic mechanism, and provide advantageous candidate antigens for the study of anti-MTB vaccines. Therefore, we review the interaction mechanism between MTB and DC.
作者 杨雨婷(综述) 杨国平 李光华 孟余(审校) YANG Yu-ting;YANG Guo-ping;LI Guang-hua;MENG Yu(Department of Medical Microbiology and Immunology,Basic Medicine College of Dali University,Dali 6710OO,Yunnan Province,China)
出处 《微生物学免疫学进展》 CAS 2021年第2期78-84,共7页 Progress In Microbiology and Immunology
基金 云南省地方本科高校联合专项面上项目(2017FH001-085) 大理大学高层次人才资助项目(KYBS201708) 大理大学临床分子免疫学创新团队(ZKLX2019105)。
关键词 结核分枝杆菌 树突状细胞 细胞因子 受体 Mycobacterium tuberculosis(MTB) Dendritic cell(DC) Cytokine Receptors
  • 相关文献

参考文献1

二级参考文献51

  • 1Zumla A, George A, Sharma V, Herbert RH, Baroness Masham of Ilton, Oxley A, Oliver M. The WHO 2014 global tuberculosis report--further to go. Lancet Glob Health 2015, 3: e10-e12.
  • 2Raviglione MC, Smith IM. XDR tuberculosis--implications for global pub- lic health. New Engl J Med 2007, 356: 656-659.
  • 3Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tu- berculous meningitis and miliary tuberculosis: a meta-analysis, lnt J Epidemiol 1993, 22: 1154-1158.
  • 4Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta- analysis of the published literature. J Am Med Assoc 1994, 271: 698-702.
  • 5Buddle BM, Wedlock DN, Parlane NA, Corner LA, De Lisle GW, Skinner MA. Revaccination of neonatal calves with Mycobacterium boris BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect Immun 2003, 71: 6411-6419.
  • 6Matsuo K, Yasutomi Y. Mycobacterium boris bacille Calmette-Guerin as a vaccine vector for global infectious disease control. Tuberc Res Treat 2011, 2011: 574591.
  • 7McShane H, Pathan AA, Sander CR, Goonetilleke NP, Fletcher HA, Hill AV. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials. Tuberculosis 2005, 85: 47-52.
  • 8Lu M, Xia ZY, Bao L. A Mycobacterium boris BCG-naked DNA prime- boost vaccination strategy induced CD4(+) and CD8(*) T-cell response against Mycobacterium tuberculosis immunogens. J Immunol Res 2014, 2014: 395626.
  • 9Lu M, Xia ZY, Bao L. Enhancement of antimycobacterial Thl-cell re- sponses by a Mycobacterium boris BCG prime-protein boost vaccination strategy. Cell lmmuno12013, 285: 111-117.
  • 10Wang C, Chen Z, Fu R, Zhang Y, Chen L, Huang L, Li J, et al. A DNA vac- cine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice. Med Microbiol Immuno12011, 200: 165-175.

共引文献1

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部